Literature DB >> 25891209

Elevated Serum Gamma-glutamyl Transpeptidase Levels and Fatty Liver Strongly Predict the Presence of Carotid Plaque.

Nobuyuki Toshikuni1, Takayoshi Asaji, Yumiko Nakanishi, Shin-ya Nagasawa, Hiroaki Uenishi, Mikihiro Tsutsumi.   

Abstract

AIM: There is a strong relationship between carotid atherosclerosis and future cardiovascular disease (CVD). This study sought to clarify the association of fatty liver and an elevated serum gamma-glutamyl transpeptidase (GGT) level with carotid atherosclerosis.
METHODS: We reviewed the medical records of subjects who underwent medical checkups at our institute. Carotid atherosclerosis and fatty liver were assessed using ultrasound (US), and predictors of increased carotid intima-media thickness (IMT) and carotid plaque were identified using a logistic regression model.
RESULTS: In total, 958 subjects (564 men, 394 women; median age, 59 years) were enrolled. The median value of the mean carotid IMT was 0.713 mm, and the frequency of carotid plaque was 19.5%. For the highest quartile of the mean carotid IMT (≥ 0.863 mm), a male sex, older age, hypertension (HT), dyslipidemia (DL) and type 2 diabetes mellitus (DM) were identified as independent predictors. A male sex, older age, HT and elevated serum GGT level were found to be significant predictors of the presence of carotid plaque. In addition, fatty liver correlated with the existence of carotid plaque. When the combination of the serum GGT level and presence or absence of fatty liver was included as a variable in the analysis, a male sex, older age, HT and fatty liver with a serum GGT level of ≥ 83 IU/L (90th percentile) (odds ratio 3.21, 95% confidence interval 1.27-8.12, p=0.014)were identified to be significantly associated with carotid plaque.
CONCLUSIONS: This study suggests that the simultaneous presence of an elevated serum GGT level and fatty liver is highly predictive of carotid plaque.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25891209     DOI: 10.5551/jat.28274

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  3 in total

1.  A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome.

Authors:  Stephanie Seneff; Robert M Davidson; Ann Lauritzen; Anthony Samsel; Glyn Wainwright
Journal:  Theor Biol Med Model       Date:  2015-05-27       Impact factor: 2.432

2.  The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people

Authors:  Kaori Kinoshita; Nobuyuki Toshikuni; Takashi Saito; Nobuhiko Hayashi; Takahiro Minato; Yasuhiro Matsue; Yoshimichi Ueda; Mutsumi Tsuchishima; Mikihiro Tsutsumi
Journal:  Turk J Med Sci       Date:  2019-10-24       Impact factor: 0.973

3.  Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics.

Authors:  Yong-Giun Kim; Gyung-Min Park; Seung Bum Lee; Dong Hyun Yang; Joon-Won Kang; Tae-Hwan Lim; Hong-Kyu Kim; Jaewon Choe; Seung-Whan Lee; Young-Hak Kim
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.